In this free webinar, learn how central blood pressure and pulse wave analysis offer critical insights for generating real-world evidence (RWE) in drug development. Attendees will learn how accurate arterial health data enhances assessments of drug efficacy and safety in trials and real-world studies. The featured speaker will discuss how central blood pressure and arterial stiffness provide more precise vascular data than traditional peripheral measurements. They will also share how enhanced arterial biomarkers support better regulatory decisions and improved therapeutic outcomes across diverse populations.
TORONTO, Nov. 12, 2024 /PRNewswire-PRWeb/ –As the pharmaceutical industry increasingly turns to real-world evidence to support drug development and regulatory decisions, the importance of accurate and comprehensive health monitoring cannot be overstated.
This webinar will explore how medical devices can be integrated into clinical trials and real-world studies to generate critical real-world evidence that informs drug efficacy and safety profiles.
Arterial health is a key determinant of the effectiveness and safety of many therapies, particularly in the context of cardiovascular disease, diabetes and other chronic conditions. Central blood pressure and arterial stiffness serve as robust biomarkers for assessing the impact of new drugs on the vascular system, providing insights that traditional peripheral measurements cannot offer.
Pharmaceutical companies require precise real-world evidence to help facilitate more informed decisions in the drug development process from early-phase trials to post-market surveillance.
Non-invasive devices that monitor arterial health through central blood pressure and pulse wave analysis (PWA) are a significant advancement in this area. This webinar will explore how medical devices can be integrated into clinical trials and real-world studies to generate critical real-world evidence that informs drug efficacy and safety profiles.
This webinar will provide a detailed look at the application of medical devices in drug development and their potential to improve therapeutic outcomes through better-informed regulatory strategies.
Register for this webinar to discover how central blood pressure and arterial stiffness serve as robust biomarkers and provide precise real-world evidence that can revolutionize drug development for cardiovascular diseases.
Join Dr. Sanjeev Bhavnani, MD, FACC, Chief Clinical Officer, Cardiex, for the live webinar on Monday, December 2, 2024, at 1pm EST (10am PST).
For more information, or to register for this event, visit Using Real-World Evidence To Enhance Drug Development: Arterial Health Monitoring Innovations.
ABOUT CARDIEX
Cardiex is a digital health technology company that develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health.
Our pioneering SphygmoCor vascular biosensing technology measures arterial health by collecting clinically meaningful digital vascular biomarkers using novel sensors. These biomarkers represent key indicators of cardiovascular health including, but not limited to, central blood pressures, vascular stiffness, vascular age, and heart stress. SphygmoCor has been deployed in multiple clinical trials sponsored by pharmaceutical companies and healthcare systems to measure arterial health.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/using-real-world-evidence-to-enhance-drug-development-arterial-health-monitoring-innovations-upcoming-webinar-hosted-by-xtalks-302302634.html
SOURCE Xtalks; Xtalks
